OTHER SYNTHETICS BILL STATUS REPORT CARRYOVER, 2013, AND SPECIAL SESSIONS AND PROPOSED REGULATIONS

This project was supported by Cooperative Agreement No. 2012-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the office of Juvenile Justice and Delinquency Prevention, the office for Victims of Crime, the Community Capacity Development Office, and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.

2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.

State

Bill No.

Description

Arizona

H.B. 2327 L.B. 645 L.B. 1109 H.B. 619

2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4

D.C. D.C.

2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 2C-T-7, 5-MeO-DiPT, AMT 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 2C-T-7, 5-MeO-DiPT, AMT Adds 2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine, fluoromethamphetamine, MPA, MXE

Florida

Florida

S.B. 294 H.B. 302

Georgia

2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine, fluoromethamphetamine, MPA, MXE Adds 2C-C, 2C-I, 25B-NBOMe, 25C-NBOMe, 25INBOMe, 5-MeO-DALT

Status and Date of Last Action Read in Senate second time 2/20/2013 Enacted 2/13/2013 Signed by Mayor; effective on signing 1/14/2013 Favorable by Criminal Justice subcommittee; now in Justice Appropriations subcommittee 2/19/2013 In judiciary committee 2/6/2013 House passed/adopted substitute 2/27/2013 Passed House; in Senate committee 2/25/2013 Passed Senate; in House committee 2/26/2013 Passed House; in Senate committee 2/21/2013 First appeared on the interim calendar 2/8/2013 Unfavorable report by Judiciary, withdrawn by sponsor 2/13/2013 No further action taken 1/1/2013 Introduced and first

Indiana

H.B. 1382 S.B. 536 H.B. 8

2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 5-MeO-DMT 2C-C-NBOMe, 25I-NBOMe

Indiana

Kentucky

2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe, 2,5I-NBOMe

Louisiana

H.B. 10

Maryland

H.B. 483

Adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 25CNBOMe, 25I-NBOH, 25I-NBOME, 2C-T-2, 2C-T-4, 4-FA, 4-FMA, 4-HO-DIPT, 5-APB, 5-APDB, 5-IAI, 5-MeO-DALT, 5-MeO-DMT, 5-MeO-MIPT, 6-APB, 6-APDB, DIPT, MXE 2C-B

Mass.

H.B. 4383 H.F.

MPHP

Minnesota

Adds 25I-NBOMe

2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.

889 Montana H.B. 140 2C-T-7, 5-MeO-DIPT, 5-MeO-DMT

Nebraska

L.B. 298

New York New York

A.B. 1285 S.B. 2441 H.B. 1070

- adds phenethylamines language with the following as examples: 2,5-DMA, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2C-B-FLY, 2CB-5hemiFLY, 2C-B-FLY-NBOMe, 2C-B-NBOMe, 2C-I-NBOH, 2C-T-2, 2C-T-4, 2C-T-7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromo-dragonFLY, DOB, DOC, DOI - adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HO-DIPT, 4-HOMET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeOMIPT TFMPP 2-AI, 2C-C, 2C-D, 2C-E, 2C-B-FLY, 3C-B-FLY, 3-MeO-PCE, 4-MeO-PCP, 5-IAI, 5-MeO-DALT, 5-MeO-DIPT, 6-APB, bromo-dragonFLY, MXE - adds substituted phenethylamines language with the following as examples: 2,5-DMA, 2C-B, 2C-C, 2C-D, 2CE, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2C-BFLY, 2CB-5-hemiFLY, 2C-B-FLY-NBOMe, 2C-B-NBOMe, 2C-C-NBOMe, 2C-I-NBOH, 2C-I-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromodragonFLY, DOB, DOC, DOI, mescaline-NBOMe - adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HO-DIPT, 4-HOMET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeOMiPT, MXE, TFMPP - adds fluoroamphetamine, fluoromethamphetamine 2C-C, 2C-D, 2C-E, 2C-I, 2C-H, 2C-N, 2C-P, 25I-NBOMe, 2C-T-2, 2C-T-4, 5-APB, 5-APDB, 5-IAI, 5-MeO-DALT, 6APB, 6-APDB, BTCP, MPA, MXE, PMMA Adds 2C-H, 25C-NBOMe, 25I-NBOMe, 2C-T-7, 4-FA, 4FMA, DBZP

reading 2/25/2013 Referred to Senate committee; scheduled for hearing 3/12 2/7/2013 Notice of hearing for 2/28 2/25/2013

Referred to committee 1/9/2013 Referred to committee 1/17/2013 Committee hearing 2/25/2013

North Dakota

Ohio

H.B. 334 H.B. 2217

Okla.

Rhode Island

H.B. 5325

Adds TFMPP

Signed by Governor; effective on signing 12/20/2012 Amended by committee substitute; committee recommends do pass 2/14/2013 Committee recommends measure be held for further study

2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.

South Carolina

S.B. 406

South Dakota

S.B. 68

Tenn.

H.B. 12

Adds 2,5-DMA, 2-AI, 2-FMA, 2C-B, 2C-C, 2C-D, 2C-D, 2CH, 2C-I, 2C-N, 2C-P, 2C-T, 25I-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 4-CAB, 4-FA, 4-FMA, 4-HO-DIPT, 4-HO-MET, 4MeO-PCP, 4-methyl-aET, 5-IAI, 5-MeO-AMT, 5-MeODALT, 5-MeO-DiPT, 5-MeO-DMT, 5-MeO-MIPT, 6-APB, DiPT, DBZP, DOB, DOC, DOI, DPT, mCPP, MPA, MXE, NMT, O-DT, pFPP, pMeOPP, TFMPP - adds 5-MeO-DMT - adds substituted phenethylamines language with the following as examples: 2C-T, DOB, DOC, DOI, 2C-BNBOMe, 2C-B-NBOMe (different structure), mescalineNBOMe, 2C-C-NBOMe, 2CB-5-hemiFLY, 2C-B-FLY, 2C-BbutterFLY, 2C-B-FLY-NBOMe, bromo-dragonFLY, 2C-INBOH, 5-APB, 5-APDB, 6-APB, 6-APDB - adds substituted tryptamines language with the following as examples: 5-MeO-DALT, 4-AcO-DMT, 4HO-MET, 4-HO-DIPT, 5-MeO-MIPT - adds DBP, fluoroamphetamine, fluoromethamphetamine, MCPP, pFPP, pMeOPP adds hydroxylmitragynine, mitragynine

2/27/2013 Referred to committee 2/21/2013

Signed by President 2/26/2013

Tenn. Texas Texas Texas Utah

S.B. 48 H.B. 1333 H.B. 1670 S.B. 264 H.B. 52

adds hydroxylmitragynine, mitragynine Adds 25I-NBOMe, 5-APB, 5-APDB, 5-IAI, 5-MeO-DALT, 6-APB, 6-APDB, BTCP, MXE Adds 25I-NBOMe adds 25I-NBOMe adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 25INBOMe, 2C-T-2, 2C-T-4, 5-IAI, 5-MeO-DALT, DiPT, DOC, fluoromethamphetamine, MXE adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-MBOMe, 2C-CNBOMe, 2C-T-2, 2C-T-4, APB, APDB

Virginia

H.B. 1843

Virginia

H.B. 1941 S.B. 1083 S.B.

adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-NBOMe, 2C-CNBOMe, 2C-T-2, 2C-T-4, APB, APDB adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-NBOMe, 2C-CNBOMe, 2C-T-2, 2C-T-4, APB, APDB adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-MBOMe, 2C-C-

Virginia

Virginia

Placed on committee calendar for 3/6 2/27/2013 Referred to committee 1/30/2013 Referred to committee 2/25/2013 Filed 2/21/2013 Referred to committee 1/29/2013 Draft of enrolled bill prepared 2/8/2013 Incorporated by Courts of Justice into H.B. 1941 1/25/2013 Signed by Speaker and President 2/22/2013 Signed by Speaker and President 2/23/2013 Incorporated by

2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.

1318

NBOMe, 2C-T-2, 2C-T-4, APB, APDB

West Virginia State Florida

S.B. 11

Adds 2C-T-7, 5-MeO-DiPT, 5-MeO-DMT

Courts of Justice into S.B. 1083 1/23/2013 Referred to committee 2/13/2013 Status and Date of Last Action Emergency rules; enacted 12/12/2012 Enacted 1/23/2013 Approved; effective 12/19 12/12/2012 Approved; effective 12/19 12/12/2012 Emergency rules; enacted 11/20/2012 Notice of intent filed 2/20/2013 Emergency rule adopted 2/20/2013 Adopted 2/21/2013 Enacted on emergency basis 11/5/2012 Adopted 1/2/2013 Enacted on emergency basis 12/3/2012 Hearing scheduled 1/9/2013

Reg. No. 312013

Description adds 2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine, fluoromethamphetamine, MPA, MXE adds 2C-C-NBOMe, 25I-NBOMe adds 2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe

Indiana Kentucky

315727 316454

Kentucky

316510

adds 2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe

Louisiana

310618

adds 25I-NBOMe

Louisiana Louisiana

318600 318619

Adds 25I-NBOMe Adds 25I-NBOMe

Nevada New York

310060 305188

adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4 adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4

North Dakota

312282

- adds substituted phenethylamines language with the following as examples: 2,5-DMA, 2C-B, 2C-C, 2C-D, 2CE, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2CB-5hemiFLY, 2C-B-FLY-NBOMe, 2C-B-NBOMe, 2C-CNBOMe, 2C-I-NBOH, 2C-I-NBOMe, 2C-T-2, 2C-T-4, 2C-T7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromo-dragonFLY, DOB, DOC, DOET, DOI, DOB, MDA, MDEA, mescalineNBOMe - adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HO-DIPT, 4-HOMET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-

2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.

Texas

318764

MIPT, DET, DMT, MXE, pTFMPP - adds fluoroamphetamine, fluoromethamphetamine Adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4

Vermont

306843

Vermont

311487

Vermont

317654

Adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-B-FLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2C-TFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25INBOMe, 3-HO-PCE, 3-HO-PCP, 3-MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4HO-MIPT, 4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeOMIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5-ME, 5-MeOAMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeODMT, 5-MeO-DPT, 5-MeO-MIPT, 5-MeO-MPMI, 6-APB, DBZP, DIPT, DPT, ethyl-ketamine, Kratom, MCPP, MeOPP, MIPT, MPA, MXE, O-DT, pFPP, TFMPP Adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-B-FLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2C-TFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25INBOMe, 3-HO-PCE, 3-HO-PCP, 3-MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4HO-MIPT, 4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeOMIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5-ME, 5-MeOAMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeODMT, 5-MeO-DPT, 5-MeO-MIPT, 5-MeO-MPMI, 6-APB, DBZP, DIPT, DPT, ethyl-ketamine, Kratom, MCPP, MeOPP, MIPT, MPA, MXE, pFPP, TFMPP Adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-B-FLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2C-TFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25INBOMe, 3-HO-PCE, 3-HO-PCP, 3-MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4HO-MIPT, 4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeOMIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5-MeO-AMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-DPT, 5-MeO-DIPT (different structure; may be 5-MeO-MIPT), 5-MeO-MPMI, 6-APB, DIPT, DPT, ethylketamine, Kratom, MCPP, MeOPP, MIPT, MPA, MXE, pFPP, TFMPP

Annual republication; effective 21 days after publication of notice 2/22/2013 Enacted on emergency basis; in effect until 4/20/2013 12/21/2012

Adopted; effective 3/2/2013 1/31/2013

Emergency rules 2/13/2013

* Red text indicates the legislative session has adjourned sine die.
2013 Research is current as of February 28, 2013. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please contact Heather Gray at (703) 836-6100, ext. 114 or hgray@namsdl.org with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite 201, Santa Fe, NM 87501.